Inside the Lab: How Scientists Study Vaccine Hesitancy
Source: National Cancer Institute via Wikimedia Commons. Highlights Qualitative research reveals why people accept or delay vaccines. Systematic reviews combine evidence from dozens of independent studies. These findings help shape vaccination policies across Latin America. When people think about vaccine research, they often imagine scientists in white lab coats developing new vaccines against viruses like…
Why Vaccine Hesitancy Persists in Latin America
A review of 56 studies reveals that vaccine hesitancy in Latin America is influenced by much more than misinformation. Trust in healthcare providers, cultural beliefs, access to vaccination services, and clear communication all shape vaccine decisions, offering valuable lessons for improving immunization coverage across the region.
How Immunoblotting Works: Detecting Proteins in Disease Research
Immunoblotting is a powerful laboratory technique that allows scientists to detect specific proteins involved in infection and immunity. By revealing how viruses interact with human cells, it provides critical insights that drive diagnostics, therapeutics, vaccine development, and public health research.
Dengue in Latin America in 2026: The Latest Outbreak Updates
Dengue remains a major public health threat across Latin America in 2026. Explore the latest PAHO outbreak data, affected countries, circulating dengue serotypes, and why health officials continue to emphasize surveillance, mosquito control, and early detection to prevent future epidemics.
Dengue Symptoms in 2026: What to Watch For
Dengue fever is spreading into new regions in 2026, driven by expanding mosquito habitats and growing outbreaks worldwide. Learn the early dengue symptoms, recognize the warning signs of severe dengue, and discover which regions face the highest risk this year.
Why Hantavirus Cases Are Rising Across Latin America
Hantavirus cases are rising across Latin America due to environmental change, rodent exposure, and climate shifts. Learn the symptoms, risks, and prevention strategies.
Why Measles Cases Are Rising Across Latin America in 2026
Measles cases are rising across Latin America in 2026 as vaccination rates decline. Learn how misinformation, migration, and health system challenges are fueling outbreaks.
Andes Hantavirus Explained: What The Cruise Ship Outbreak Means
A rare Andes hantavirus outbreak aboard a cruise ship has drawn global attention after multiple deaths and confirmed human-to-human transmission. Here is what the outbreak means for public health, travel, and Latin America.
CRISPR vs PCR for Virus Detection: Why It Matters for Public Health
CRISPR diagnostics aren’t replacing Polymerase Chain Reaction yet—but they’re redefining what rapid virus detection can look like. As CRISPR tools advance and gain approval, they are poised to bring faster, more accessible testing closer to the communities that need it most.
Dengue Vaccines in Latin America: What’s Approved and Where They’re Being Used
Latin America faces rising dengue cases driven by climate and vector spread. This article explores available vaccines and their uneven distribution across the region.
Inside H. pylori Survival: How This Bacterium Thrives in Harsh Conditions
Helicobacter pylori can survive beyond the human stomach by entering a dormant state and forming protective biofilms in water systems. This hidden persistence raises new concerns for drinking water safety and disease transmission in Latin America.
Inside the Lab: How ELISA Detects Infection in Blood
ELISA is a widely used diagnostic tool that detects antibodies or antigens in blood, helping identify infections and track disease spread. By enabling large-scale testing, it plays a critical role in public health surveillance and outbreak response, especially in regions like Latin America.
